ATE364079T1 - Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung - Google Patents

Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung

Info

Publication number
ATE364079T1
ATE364079T1 AT93911529T AT93911529T ATE364079T1 AT E364079 T1 ATE364079 T1 AT E364079T1 AT 93911529 T AT93911529 T AT 93911529T AT 93911529 T AT93911529 T AT 93911529T AT E364079 T1 ATE364079 T1 AT E364079T1
Authority
AT
Austria
Prior art keywords
peptides
nucleic acid
acid sequences
sequences coding
production
Prior art date
Application number
AT93911529T
Other languages
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE364079T1 publication Critical patent/ATE364079T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT93911529T 1992-04-21 1993-04-19 Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung ATE364079T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9204827A FR2690162B1 (fr) 1992-04-21 1992-04-21 Peptides ayant une activite de facteur d'echange du gdp, sequences d'acides nucleiques codant pour ces peptides, preparation et utilisation.

Publications (1)

Publication Number Publication Date
ATE364079T1 true ATE364079T1 (de) 2007-06-15

Family

ID=9429043

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911529T ATE364079T1 (de) 1992-04-21 1993-04-19 Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung

Country Status (11)

Country Link
US (1) US5656595A (de)
EP (1) EP0637334B1 (de)
JP (1) JP3681384B2 (de)
AT (1) ATE364079T1 (de)
CA (1) CA2131166A1 (de)
DE (1) DE69334146T2 (de)
DK (1) DK0637334T3 (de)
ES (1) ES2287927T3 (de)
FR (1) FR2690162B1 (de)
PT (1) PT637334E (de)
WO (1) WO1993021314A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840683A (en) * 1995-09-21 1998-11-24 Innapharma, Inc. Peptides inhibiting the oncogenic action of p21 ras
US5910478A (en) * 1995-09-21 1999-06-08 Innapharma, Inc. Peptidomimetics inhibiting the oncogenic action of p21 ras
US6340575B1 (en) * 1997-06-17 2002-01-22 Onyx Pharmaceuticals, Inc. Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity
IT1293491B1 (it) * 1997-07-08 1999-03-01 Dompe Spa Mutanti di proteine gef e plasmidi idonei per la loro sintesi
US6177545B1 (en) * 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US6699672B1 (en) * 1997-09-02 2004-03-02 Insight Biopharmaceuticals Ltd. Heparanase specific molecular probes and their use research and medical applications
US20040213789A1 (en) * 1997-09-02 2004-10-28 Oron Yacoby-Zeevi Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US20020088019A1 (en) * 1997-09-02 2002-07-04 Oron Yacoby-Zeevi Methods of and pharmaceutical compositions for improving implantation of embryos
US20030217375A1 (en) * 1998-08-31 2003-11-20 Eyal Zcharia Transgenic animals expressing heparanase and uses thereof
IT1306190B1 (it) * 1999-01-04 2001-05-30 Dipartimento Di Biotecnologie Mutanti di proteine e plasmidi idonei per la loro sintesi.
EP1157118A4 (de) * 1999-03-01 2002-07-17 Insight Strategy & Marketing POLYNUKLEOTID, DAS FüR EIN POLYPEPTID MIT HEPARANASE-AKTIVäT KODIERT, UND DESSEN EXPRESSION IN GENETISCH VERäNDERTEN ZELLEN
EP1278848A1 (de) * 2000-05-05 2003-01-29 MERCK PATENT GmbH Neuer ras-guanin-nukleotid-austauschfaktor-1 (nrg1)
FR2812945B1 (fr) * 2000-08-10 2002-10-04 Aventis Pharma Sa Utilisation de la proteine grf1 et cellules exprimant la proteine grf1 pour le criblage de molecules
WO2002055704A2 (en) 2001-01-09 2002-07-18 Curagen Corp Proteins, polynucleotides encoding them and methods of using the same
US6671189B2 (en) * 2001-11-09 2003-12-30 Minebea Co., Ltd. Power converter having primary and secondary side switches
US7291725B2 (en) * 2002-06-26 2007-11-06 Chiron Corporation Sos1 inhibitors
WO2004064479A2 (en) * 2003-01-17 2004-08-05 Children's Medical Center Corporation Neuroprotective therapeutics and assays for identifying the same
WO2004108065A2 (en) * 2003-06-09 2004-12-16 Insight Biopharmaceuticals Ltd. Heparanase activity neutralizing anti- heparanase monoclonal antibody and other anti-heparanase antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0491828B1 (de) * 1989-08-21 1999-06-16 Chiron Corporation Vom gtpase-aktivierenden protein (gap) abgeleitete peptide sowie deren diagnostische und therapeutische verwendung

Also Published As

Publication number Publication date
US5656595A (en) 1997-08-12
CA2131166A1 (fr) 1993-10-28
WO1993021314A1 (fr) 1993-10-28
JP3681384B2 (ja) 2005-08-10
DK0637334T3 (da) 2007-10-08
DE69334146D1 (de) 2007-07-19
EP0637334B1 (de) 2007-06-06
EP0637334A1 (de) 1995-02-08
DE69334146T2 (de) 2008-01-31
ES2287927T3 (es) 2007-12-16
FR2690162B1 (fr) 1995-08-04
FR2690162A1 (fr) 1993-10-22
PT637334E (pt) 2007-09-07
JPH07505774A (ja) 1995-06-29

Similar Documents

Publication Publication Date Title
ATE364079T1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
DE69326250D1 (de) Neuropeptide y antagoniste
FI962591A (fi) Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä
ATE178072T1 (de) Neuartige polypeptide und ihre verwendung
DE69900756T2 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
DE69312232T2 (de) Bpc-peptide, ihre herstellung und verwendung
DE3582895D1 (de) Peptid, dessen herstellung und benutzung.
DE69530404D1 (de) Analogen des keratinozytenwachstumfaktors
ATE242202T1 (de) Peptide
AU669149B2 (en) Expression signal-peptide-free staphylokinases
ATE213742T1 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
DE58906606D1 (de) Optisch aktive Rhodiumkomplexe von 3,4-Bis(diarylphosphino)-pyrrolidinen und ihre Verwendung zur Herstellung von Phosphinothricin durch asymmetrische Hydrierung.
ATE254179T1 (de) Neue type-i-interferon varianten, ihre verfahren zur herstellung, und ihre verwendungen
DE69534596D1 (de) Epil/plazentin
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
DE68908958T2 (de) Peptide.
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
WO1990003394A3 (fr) Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0637334

Country of ref document: EP

REN Ceased due to non-payment of the annual fee